WHO ICTRP trial
A phase I-IIa clinical trial, evaluating the therapeutic vaccine…
EUCTR2013-002663-25-NL · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2013-002663-25-NL |
|---|---|
| Public title | A phase I-IIa clinical trial, evaluating the therapeutic vaccine hVEGF26-104/RFASE in patients with advanced cancer |
| Scientific title | A phase I- IIa open-label clinical trial, evaluating the therapeutic vaccine hVEGF26-104/RFASE in patients with advanced solid tumors |
| Primary sponsor | VU University Medical Center |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): yes Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Netherlands |
| Conditions | Advanced solid tumors MedDRA version: 16.0 Level: LLT Classification code 10048683 Term: Advanced cancer System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04] |
| Interventions | Product Name: hVEGF26-104 Pharmaceutical Form: Solution for injection INN or Proposed INN: hVEGF26-104 Current Sponsor code: hVEGF26-104 Concentration unit: µg/ml microgram(s)/millilitre Concentration type: equal Concentration number: 500… |
| Registration date | Jul 18, 2013 |
| Target size | 35 |
| Secondary IDs | VEGFVAX |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: